Leading Pharma, LLC: Drug Recall
Recall #D-1546-2022 · 08/23/2022
Class III: Low Risk
Recall Details
- Recall Number
- D-1546-2022
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Leading Pharma, LLC
- Status
- Terminated
- Date Initiated
- 08/23/2022
- Location
- Fairfield, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 bottles (100 capsules)
Reason for Recall
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
Product Description
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
Distribution Pattern
Nationwide within the United States
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.